NCT04930666Completed
BREATHE ALD: A Shared Decision-Making Intervention for Adults With Advanced Lung Disease
The Development and Pilot Testing of a Brief Shared Decision-Making Intervention to Improve Palliative Care Outcomes for Adults With Advanced Lung Disease
Source: ClinicalTrials.gov · Last updated 15 Apr 2025
Brief summary (registry, in English)
This study aims to: 1. Develop the BREATHE-ALD intervention for adults with Advanced Lung Disease, multiple chronic conditions, and palliative care needs and their caregivers using interviews with 10 advanced lung disease (ALD) adults and their caregivers 2. To evaluate the feasibility and acceptability of intervention procedures; and 3. To explore intervention effects on ALD outcomes
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 30 (actual)
- First submitted
- 11 Jun 2021
- Start date
- 10 Nov 2021
- Primary completion date
- 6 Feb 2025
- Lead sponsor
- Columbia University
- Diseases
- COPD
- NCT number
- NCT04930666
What you commit to
- Study type: Observational
- Participants enrolled: 30
- From 10 Nov 2021 to the primary completion date, 6 Feb 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients that have serious mental health conditions that preclude completion of study procedures or confound analyses.
- Caregivers that have serious mental health conditions that preclude completion of study procedures or confound analyses.
- Trial
- Patients that have serious mental health conditions that preclude completion of study procedures or confound analyses.
Other
- Patients anticipated to have less than 3-month survival.
Who the study is looking for
- Patient participants with symptomatic advanced lung disease (ALD) followed at Weill Cornell Medicine (WCM).
- Caregiver participants who care for adults with symptomatic ALD followed at Weill Cornell Medicine.
- Patient participants with symptomatic advanced lung disease (ALD) followed at Weill Cornell Medicine (WCM).
- Nurse practitioner must manage a panel of adult ALD patients.
Criteria the registry did not label
- Pre-trial
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Weill Cornell Medical Center Coordinator of this site? Confirm its status | New York | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.